
    
      80-90% patients of ESFT will develope disease progression during the period of local
      treatment (surgery or radiation). The survival has been improved in these 30 years due to
      chemotherapy. VCD/IE is widely used in the world for the patients with ESFT, but it is rarely
      used in China due to its high dosage.
    
  